Literature DB >> 11721964

Analysis of the distribution of CAG repeats and X-chromosome inactivation status of HUMARA gene in healthy female subjects using improved fluorescence-based assay.

M Karasawa1, N Tsukamoto, A Yamane, K Okamoto, T Maehara, A Yokohama, Y Nojima, M Omine.   

Abstract

We investigated the polymorphic CAG-repeat distribution and the X-inactivation status of the human androgen receptor (HUMARA) gene in 58 female Japanese volunteers. Polymerase chain reaction amplification was performed using a fluorescent-dye-labeled primer under conditions specific for GC-rich targets, and fragments were analyzed. To estimate the length of these fragments, FAM-labeled (blue fluorescent) products were simultaneously compared with ROM-labeled size markers (red) that were created by sequencing various HUMARA fragments. The number of polymorphic CAG repeats of HUMARA in 116 alleles from 58 female subjects ranged from 15 to 28. Of the 58 volunteers, 51 (88.0%) were heterozygous. In 96% of the heterozygous female subjects, the allelic differences were no greater than 6 repeats. X-chromosome inactivation was calculated as the ratio of the area of the smaller peak to the sum of the areas of the smaller and larger peaks. The average ratio was 0.38 (range, 0.09-0.50). Preferential use of 1 allele, by more than 75% (ratio. <0.25). was observed in 5 volunteers (10.9%). The clonal nature of a patient with chronic myelogenous leukemia was easily identified. This method is sensitive enough to discriminate a difference of 1 triplet repeat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721964     DOI: 10.1007/bf02982062

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups.

Authors:  A Edwards; H A Hammond; L Jin; C T Caskey; R Chakraborty
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

2.  Using fluorescence-based human androgen receptor gene assay to analyze the clonality of microdissected dendritic cell tumors.

Authors:  C D Wu; R S Wickert; J E Williamson; N C Sun; R K Brynes; W C Chan
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

3.  Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age.

Authors:  R E Gale; A K Fielding; C N Harrison; D C Linch
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

4.  Characterization and expression of a cDNA encoding the human androgen receptor.

Authors:  W D Tilley; M Marcelli; J D Wilson; M J McPhaul
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Reduced androgen receptor gene expression with first exon CAG repeat expansion.

Authors:  C S Choong; J A Kemppainen; Z X Zhou; E M Wilson
Journal:  Mol Endocrinol       Date:  1996-12

Review 6.  Use of genetic markers to study cellular origin and development of tumors in human females.

Authors:  P J Fialkow
Journal:  Adv Cancer Res       Date:  1972       Impact factor: 6.242

7.  Unbalanced X-chromosome inactivation in haemopoietic cells from normal women.

Authors:  L Tonon; G Bergamaschi; C Dellavecchia; V Rosti; C Lucotti; L Malabarba; A Novella; E Vercesi; F Frassoni; M Cazzola
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

8.  Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age.

Authors:  L Busque; R Mio; J Mattioli; E Brais; N Blais; Y Lalonde; M Maragh; D G Gilliland
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

9.  PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies.

Authors:  G L Mutter; K A Boynton
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

10.  The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

Authors:  R A Irvine; M C Yu; R K Ross; G A Coetzee
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

View more
  6 in total

1.  Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2.

Authors:  A Saxena; D de Lagarde; H Leonard; S L Williamson; V Vasudevan; J Christodoulou; E Thompson; P MacLeod; D Ravine
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

2.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

3.  X-chromosome inactivation patterns in females with Prader-Willi syndrome.

Authors:  Merlin G Butler; Mariana F Theodoro; Douglas C Bittel; Paul J Kuipers; Daniel J Driscoll; Zohreh Talebizadeh
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

4.  Brief report: non-random X chromosome inactivation in females with autism.

Authors:  Z Talebizadeh; D C Bittel; O J Veatch; N Kibiryeva; M G Butler
Journal:  J Autism Dev Disord       Date:  2005-10

5.  Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome.

Authors:  Kohtaro Toyama; Masamitsu Karasawa; Arito Yamane; Hiromi Koiso; Akihiko Yokohama; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Ken Sato; Hitoshi Takagi; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.490

6.  Use of the FMR1 Gene Methylation Status to Assess the X-Chromosome Inactivation Pattern: A Stepwise Analysis.

Authors:  Bárbara Rodrigues; Ana Gonçalves; Vanessa Sousa; Nuno Maia; Isabel Marques; Emídio Vale-Fernandes; Rosário Santos; António J A Nogueira; Paula Jorge
Journal:  Genes (Basel)       Date:  2022-02-25       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.